Tc Biopharm (Holdings) Plc盘中异动大幅下挫12.72%

市场透视2025-02-03

北京时间2025年02月03日22时31分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现异动，股价大幅跳水12.72%。截至发稿，该股报0.324美元/股，成交量10.9431万股，换手率1.07%，振幅11.75%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.51百万美元，每股收益-6.06美元，毛利-152137.55美元，市盈率-0.00倍...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2508014138?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-03 22:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2508014138","market":"us","top_or_hot":-1,"title":"Tc Biopharm (Holdings) Plc盘中异动 大幅下挫12.72%","media":"市场透视","content":"<div>\n<p>北京时间2025年02月03日22时31分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现异动，股价大幅跳水12.72%。截至发稿，该股报0.324美元/股，成交量10.9431万股，换手率1.07%，振幅11.75%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.51百万美元，每股收益-6.06美元，毛利-152137.55美元，市盈率-0.00倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223139a2380920&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tc Biopharm (Holdings) Plc盘中异动 大幅下挫12.72%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTc Biopharm (Holdings) Plc盘中异动 大幅下挫12.72%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-03 22:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223139a2380920&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月03日22时31分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现异动，股价大幅跳水12.72%。截至发稿，该股报0.324美元/股，成交量10.9431万股，换手率1.07%，振幅11.75%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.51百万美元，每股收益-6.06美元，毛利-152137.55美元，市盈率-0.00倍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223139a2380920&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TCBP","symbol_name":"TC BioPharm","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223139a2380920&s=b","article_id":"2508014138","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223139a2380920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2508014138","pubTimestamp":1738593099,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月03日22时31分，Tc Biopharm  Plc股票出现异动，股价大幅跳水12.72%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为312.39%、200.61%、126.16%，振幅较大的相关个股有Tc Biopharm  Plc、Briacell Therapeutics Corp.、Biocardia, Inc.，振幅分别为11.75%、6.97%、6.48%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"TCBP":"TC BioPharm","BK4139":"生物科技"},"translate_title":"Tc Biopharm (Holdings) Plc fell sharply by 12.72% during the session","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TCBP":0.9},"content_text":"北京时间2025年02月03日22时31分，Tc Biopharm (Holdings) Plc（TCBP.us）股票出现异动，股价大幅跳水12.72%。截至发稿，该股报0.324美元/股，成交量10.9431万股，换手率1.07%，振幅11.75%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.51百万美元，每股收益-6.06美元，毛利-152137.55美元，市盈率-0.00倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Tc Biopharm (Holdings) Plc股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为312.39%、200.61%、126.16%，振幅较大的相关个股有Tc Biopharm (Holdings) Plc、Briacell Therapeutics Corp.、Biocardia, Inc.，振幅分别为11.75%、6.97%、6.48%。Tc Biopharm (Holdings) Plc公司简介：TC BioPharm (Holdings) PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T（缩写为 GD-T）细胞平台的新型免疫治疗产品。 利用 GD-T 的先天能力，该公司能够开发出一系列旨在对抗癌症和病毒感染的临床阶段细胞疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2508014138","isCrawlerRequest":true}

Tc Biopharm (Holdings) Plc盘中异动 大幅下挫12.72%

精彩评论

Tc Biopharm (Holdings) Plc盘中异动大幅下挫12.72%